login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
PLURISTEM THERAPEUTICS INC (PSTI) Stock News
USA
- NASDAQ:PSTI -
US72940R3003
-
Common Stock
1
USD
-0.03 (-2.91%)
Last: 7/25/2022, 8:17:24 PM
1.03
USD
+0.03 (+3%)
After Hours:
7/25/2022, 8:17:24 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PSTI Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Benzinga
- Mentions:
CLDX
BRT
TMO
A New Era In Regenerative Medicine? BioRestorative Therapies (NASDAQ: BRT) Reports Leading The Expansion Of The Adipose-Derived Stem Cell Therapy Market
3 years ago - By: Benzinga
- Mentions:
IBB
AZN
KKR
SYN
...
Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact
3 years ago - By: Pluristem Therapeutics, Inc.
- Mentions:
PLUR
Pluri CEO Issues Shareholder Update
3 years ago - By: Pluristem Therapeutics, Inc.
- Mentions:
PLUR
Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.” Reflecting the Company’s Strategy to Leverage its Innovative 3D Cell-based Technology Platform to Additional Industries
3 years ago - By: Pluristem Therapeutics, Inc.
Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture Surgery
3 years ago - By: Pluristem Therapeutics, Inc.
Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New Partnership
4 years ago - By: Pluristem Therapeutics, Inc.
Pluristem Releases PLX-R18 Hematology Phase I Study Results: Data Show Increase in All Blood Lines and Reduction in Blood Transfusions
4 years ago - By: Pluristem Therapeutics, Inc.
Pluristem and Tnuva Appoint Food Tech Veteran Eyal Rosenthal as Chief Executive Officer of their New Joint Venture
4 years ago - By: InvestorPlace
- Mentions:
IO
BBI
MYNZ
CPOP
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
4 years ago - By: PennyStocks.com
- Mentions:
RVPH
DOGZ
Best Penny Stocks to Buy Right Now? 3 For Your List in January
4 years ago - By: InvestorPlace
- Mentions:
MOLN
RVPH
APR
OMI
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
4 years ago - By: Pluristem Therapeutics, Inc.
Biotechnology Company Pluristem, and Israel’s Largest Food Producer Tnuva, Launch Landmark Collaboration to Establish Cultured Food Platform
Please enable JavaScript to continue using this application.